Sovremennyy podkhod k lecheniyu nerezektabel'noy i metastaticheskoy melanomy. Rol' ingibitorov BRAF i MEK

Autor: Daniil L'vovich Stroyakovskiy

Publikováno v: Современная онкология, Vol 17, Iss 3, Pp 10-13 (2015)

Были рассмотрены подходы к лечению метастатической меланомы и определено место ингибиторов BRAF и MEK.

Externí odkaz: https://doaj.org/article/cce99e6be82944478c145d86826011c7

Primenenie kombinatsii ingibitorov BRAF i MEK u patsientov s BRAF+ metastaticheskoy melanomoy

Autor: Yuliya Vyacheslavovna Vakhabova

Publikováno v: Современная онкология, Vol 17, Iss 3, Pp 18-20 (2015)

Выступление было посвящено разбору клинических случаев. В ФГБУ РОНЦ им. Н.Н.Блохина было проведено клиническое исследование МЕК116513 по п�

Externí odkaz: https://doaj.org/article/6e1e0c0832b74c6e9fd2e827254b2d59

Osobennosti korrektsii naibolee chastykh nezhelatel'nykh yavleniy na fone primeneniya ingibitorov BRAF i MEK

Autor: Igor' Vyacheslavovich Samoylenko

Publikováno v: Современная онкология, Vol 17, Iss 3, Pp 17-18 (2015)

Выступление было посвящено интерактивному разбору клинических случаев.

Externí odkaz: https://doaj.org/article/6d002fe2488647949a9823affbe2bdf2

Adjuvant treatments in melanoma

Autor: Simetić, Luka, Blažević, Krešimir, Herceg, Davorin

Publikováno v: Libri Oncologici, Vol 49, Iss 2-3, Pp 113-117 (2021)
Libri Oncologici : Croatian Journal of Oncology
Volume 49
Issue 2-3

For decades, interferon-alpha (IFN-α) has been the only option in the adjuvant treatment of high-risk melanoma. Despite numerous clinical trials and meta-analyzes, IFN-α is not yet a gold standard. It indeed showed benefit in progressionfree surviv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0d40279efe853ba16a5212a756db5fc
https://doi.org/10.20471/lo.2021.49.02-03.16

Associations between emotional support and cardiovascular risk factors and subclinical atherosclerosis in middle-age.

Autor: Nordin S; Department of Psychology, Umeå University, Umeå, Sweden., Norberg M; Section of Medicine, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden., Braf I; Department of Psychology, Umeå University, Umeå, Sweden., Johansson H; Department of Epidemiology and Global Health, Umeå University, Umeå, Sweden., Lindahl B; Section of Sustainable Health, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden., Lindvall K; Department of Epidemiology and Global Health, Umeå University, Umeå, Sweden., Nordin M; Department of Psychology, Umeå University, Umeå, Sweden., Nyman E; Heart Centre and Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden., Vallström C; Department of Psychology, Umeå University, Umeå, Sweden., Wennberg P; Section of Family Medicine, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden., Liv P; Section of Sustainable Health, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden., Näslund U; Heart Centre and Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Publikováno v: Psychology & health [Psychol Health] 2023 Nov 23, pp. 1-15. Date of Electronic Publication: 2023 Nov 23.